You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

ECLS can be a life-saver for ARDS patients

The mortality rate for severe acute respiratory distress syndrome (ARDS) remains high. Acute respiratory failures have become the most common indications for ECMO therapy in adults.[1] As more specialized centers adopt ECLS, there are an increasing number of reports available that show improved outcomes for adult patients with ARDS.[2]

ECLS to treat respiratory failure

ARDS refers to acute widespread pulmonary inflammation due to various causes such as trauma, infections, pneumonia and sepsis. The mortality rate for patients with ARDS ranges from 34 to 58% [3] and is widely based on severity, the patient's age and the presence of other underlying medical conditions.

The CARDIOHELP System facilitates protective ventilation strategies even in severe cases of acute respiratory failure.

The CARDIOHELP System supports pulmonary function

The veno-venous use of the CARDIOHELP System ensures an effective oxygen supply and/or the reduction of blood CO2 levels in intensive care patients suffering from ARDS, sepsis or other conditions associated with acute respiratory failure. In this way the CARDIOHELP System facilitates protective ventilation strategies even in the most severe cases.

Moreover, CARDIOHELP prevents circulatory shock or damage to internal organs, minimizing follow-up costs associated with irreversible organ damage. The use of this therapy option therefore saves valuable time, which can then be used to treat the actual cause of an organ failure.

Unless otherwise specified, all product and service names on this website are trademarks owned by or licensed to Getinge AB, its subsidiaries or affiliates. No trademark, trade name, or trade dress on this website may be used without the prior written authorization of Getinge AB. Getinge, Getinge Group, Getinge Passion for Life, Maquet, and Atrium are trademarks or registered trademarks of Getinge AB, its worldwide subsidiaries or affiliates. Org No. 556408-5032

This website is intended to provide information to an international audience outside of the US.